These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21470456)

  • 21. Developing audit standards required for outbreaks of communicable diseases-lessons from a mumps outbreak.
    Kipping RR; Hamilton S; Roderick M; Alexander K
    J Public Health (Oxf); 2006 Dec; 28(4):347-50. PubMed ID: 17065178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study.
    Westphal DW; Eastwood A; Levy A; Davies J; Huppatz C; Gilles M; Lyttle H; Williams SA; Dowse GK
    Lancet Infect Dis; 2019 Feb; 19(2):177-184. PubMed ID: 30558994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A secondary school outbreak of mumps following the childhood immunization programme in England and Wales.
    Wehner H; Morris R; Logan M; Hunt D; Jin L; Stuart J; Cartwright K
    Epidemiol Infect; 2000 Feb; 124(1):131-6. PubMed ID: 10722140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mumps epidemic--United kingdom, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(7):173-5. PubMed ID: 16498380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy.
    Melgar M; Yockey B; Marlow MA
    Epidemics; 2022 Sep; 40():100594. PubMed ID: 35728505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
    Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
    N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mumps outbreak in private schools: public health lessons for the post-Wakefield era.
    Calvert N; Ashton JR; Garnett E
    Lancet; 2013 May; 381(9878):1625-6. PubMed ID: 23628443
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mumps].
    Lajarrige C
    Soins; 1979 May; 24(10):21-4. PubMed ID: 256634
    [No Abstract]   [Full Text] [Related]  

  • 31. Severity of mumps disease is related to MMR vaccination status and viral shedding.
    Gouma S; Hahné SJ; Gijselaar DB; Koopmans MP; van Binnendijk RS
    Vaccine; 2016 Apr; 34(16):1868-73. PubMed ID: 26954106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mumps outbreaks: Implementation of a third dose of mumps-containing vaccine.
    Berlin KJ; Hayney MS
    J Am Pharm Assoc (2003); 2018; 58(5):577-578. PubMed ID: 30190108
    [No Abstract]   [Full Text] [Related]  

  • 33. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.
    Beleni AI; Borgmann S
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.
    da Silveira CM; Kmetzsch CI; Mohrdieck R; Sperb AF; Prevots DR
    Int J Epidemiol; 2002 Oct; 31(5):978-82. PubMed ID: 12435771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.
    Lam E; Rosen JB; Zucker JR
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complications of mumps in children in light of personal observations].
    Zarzycka-Chroł E; Smukalska E; Sawilska-Tańska M
    Pediatr Pol; 1995 Oct; 70(10):841-5. PubMed ID: 8649931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule.
    Gay N; Miller E; Hesketh L; Morgan-Capner P; Ramsay M; Cohen B; Brown D
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R21-6. PubMed ID: 9046125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T; McIntyre P; Roberton D; Descamps D
    Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada.
    Rudnick W; Wilson S; Majerovich JA; Haavaldsrud M; Gatali M; Matsumoto CL; Deeks S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1870909. PubMed ID: 34292135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Considerations on the complications of epidemic parotitis].
    Izzi GC; Montanarini G; Benaglia G; Ghirardini G; Cassaro F; Malvicini R
    Pediatr Med Chir; 1983; 5(6):575-8. PubMed ID: 6681062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.